Provexis PLC (PXS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.452p
Buy
0.545p
-0.0415p (-8.32%)
Prices updated at 28 May 2025, 11:38 BST
| Prices minimum 15 mins delay
Prices in GBX
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.46p - 0.46p | |
0.80p - 0.40p | |
- | |
11.71m | |
- | |
750,000 | |
3,000 | |
13.23 | |
856,729.75 | |
0.58 | |
2,217.82m | |
GB00B0923P27 | |
0.00 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.